Ideaya Biosciences
Last updated: January 01, 2024
Yujiro S. Hata, Founder and CEO
Country: USA | Funding: $431.1M (+)
Website: https://www.ideayabio.com/
IDEAYA is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines for genetically defined patient populations and immuno-oncology therapies targeting immuno-metabolism and innate immunity.
Website: https://www.ideayabio.com/
IDEAYA is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines for genetically defined patient populations and immuno-oncology therapies targeting immuno-metabolism and innate immunity.